Fubon Bank

Fubon Bank is providing a wide range of financial services encompassing consumer and wholesale banking and investment services. Fubon Bank (Hong Kong) Limited ("Fubon Bank") is a wholly owned subsidiary of Fubon Financial Holding Co., Ltd. ("Fubon Financial Holdings"), one of the largest financial holding companies in Taiwan. Fubon Financial Holdings is now the only Taiwanese financial institution with banking subsidiaries in China, Taiwan and Hong Kong. Fubon Financial Holdings acquired a 75% stake from the Bank's former shareholders, Arab Banking Corporation (B.S.C.) and China Everbright Limited in April 2004. The Bank formally adopted the name Fubon Bank on 6 April 2005. Following the successful privatization of the Bank by Fubon Financial Holdings, Fubon Bank became a wholly owned subsidiary of Fubon Financial Holdings in June 2011. Fubon Bank operates 22 branches and 2 Securities Services Centres in Hong Kong, providing a wide range of financial services encompassing consumer and wholesale banking, wealth management, financial markets, securities brokerage and investment services. Fubon Bank holds an A-2 short-term, BBB+ long-term rating from Standard & Poor's. The rating reflects Fubon Bank's strong capitalization, good liquidity and sound asset quality.

1 past transactions

Optimer Pharmaceuticals

Series D in 2005
Optimer Pharmaceuticals is a biopharmaceutical company dedicated to discovering, developing, and commercializing anti-infective products, particularly those targeting gastrointestinal infections. The company has advanced two late-stage product candidates, fidaxomicin and Pruvel, which address significant medical needs where existing therapies are inadequate. Optimer's portfolio also includes additional candidates such as CEM-101 and a combination therapy involving OPT-822/OPT-821, reflecting its commitment to developing hospital specialty products that positively impact patient health and the healthcare system. By focusing on treatments for conditions like Clostridium difficile-associated diarrhea, Optimer aims to enhance patient outcomes and alleviate the burden of infectious diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.